Alpha Tau Medical LTD.
Nasdaq DRTS · Jerusalem, Israel
Works in Dermatology · GI & liver · Infectious disease · Metabolic & endocrine · Oncology · Ophthalmology · Renal & urogenital · Respiratory · Women's health
Alpha Tau Medical LTD. is a clinical trial sponsor based in Jerusalem, Israel, listed as Nasdaq DRTS. It has 20 active clinical trials with 687 planned participants, across 9 therapeutic areas. Since 2021 it has completed 6 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq DRTS
Pipeline · 20 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Alpha Tau Medical LTD
Alpha Tau Medical LTD is lead sponsor of 20 active clinical trials on ClinicalTrials.gov, with 687 planned participants, in Dermatology, GI & liver, Infectious disease, Metabolic & endocrine and other areas. Since 2021 it has completed 6 trials and stopped 2 early.
Alpha Tau Medical LTD is based in Jerusalem, Israel and is listed as Nasdaq DRTS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Alpha Tau Medical LTD; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-27.
Approve Suite is not affiliated with Alpha Tau Medical LTD..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.